Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

DL-threo-1-Phenyl-2-decanoylamino-3-morpholino-1-propanol

Glucosylceramide synthetase inhibitor
 
BML-SL210-0010 10 mg 56.00 USD
 
BML-SL210-0050 50 mg 232.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-420-013

Blocks glucosylation of ceramide by inhibiting UDP-glucose:ceramide glucosyltransferase (glucosylceramide synthetase). Inhibits the expression of cell surface glycolipid antigens and inhibits the growth of cultured rabbit skin fibroblasts. Possesses antitumor activity and inhibits Lewis lung carcinoma cell metastasis in vitro. Useful tool for studying the effects of cellular glycosphingolipid depletion. Enhances the apoptotic response to ionizing radiation by enhancing the ceramide signal.

Product Specification

Alternative Name:D,L-threo-PDMP . hydrochloride, DL-PDMP
 
Formula:C23H38N2O3 . HCl
 
MW:390.6 . 36.5
 
CAS:80938-69-8
 
Purity:≥98% (TLC)
 
Appearance:White to off-white solid.
 
Solubility:25mg/ml soluble in 100% ethanol, DMSO or water (50°C, vortex or sonicate).
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Use/Stability:Stable for up to 1 year after receipt when stored at -20°C. Solutions are stable for up to 3 months when stored at -20°C.
 
Technical Info/Product Notes:Note: Product is not sterile.
 
bml-sl210
Please mouse over
bml-sl210

Product Literature References

Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing: C. Rodriguez-Lafrasse, et al.; Int. J. Cancer 101, 589 (2002), Abstract;
Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases: C.S. Rani, et al.; J. Biol. Chem. 270, 2859 (1995), Abstract; Full Text
Effects of a sphingolipid synthesis inhibitor on membrane transport through the secretory pathway: A.G. Rosenwald; Biochemistry 31, 3581 (1992), Abstract;
Rapid kidney changes resulting from glycosphingolipid depletion by treatment with a glucosyltransferase inhibitor: G.S. Shukla, et al.; Biochim. Biophys. Acta 1083, 101 (1991), Abstract;
Use of PDMP for the Study of Glycosphingolipid Functions: N.S. Radin and J.-I. Inokuchi; Trends Glycosci. Glycotechnol. 3, 200 (1991), Full Text
Effect of an inhibitor of glucosylceramide synthesis on cultured rabbit skin fibroblasts: K.-I. Uemura, et al.; J. Biochem. 108, 525 (1990), Abstract;
Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action: J.-I. Inokuchi, et al.; Cancer Res. 50, 6731 (1990), Abstract;
Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells: J.-I. Inokuchi, et al.; J. Cell Physiol. 141, 573 (1989), Abstract;
Antitumor activity via inhibition of glycosphingolipid biosynthesis: J.-I. Inokuchi, et al.; Cancer Lett. 38, 23 (1987), Abstract;
Preparation of the active isomer of 1-phenyl-2-decanoylamino-3- morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase: J. Inokuchi & N.S. Radin; J. Lipid Res. 28, 565 (1987), Abstract;
Analogs of ceramide that inhibit glucocerebroside synthetase in mouse brain: R.R. Vunnam & N.S. Radin; Chem. Phys. Lipids 26, 265 (1980), Abstract;

Related Literature

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

Product Flyers
Cell Cycle - Mitosis, CDKS & Cell Cycle Signaling
Cell Cycle - Mitosis, CDKS & Cell Cycle Signaling
Download as PDF

Product Flyers
Exclusive Sphingosine Kinase 1 Inhibitor
Exclusive Sphingosine Kinase 1 Inhibitor
Download as PDF

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,